-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 OJLbzeuV8zhYlOZAkHdDZ6fhUCXbc4etTOcviP0L2bJcQDVmr160C+1dbgHVtGJ1
 gwjeudkAbzNCUx7nfKERBg==

<SEC-DOCUMENT>0001096906-10-000074.txt : 20100312
<SEC-HEADER>0001096906-10-000074.hdr.sgml : 20100312
<ACCEPTANCE-DATETIME>20100122172638
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001096906-10-000074
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20100122

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UTAH MEDICAL PRODUCTS INC
		CENTRAL INDEX KEY:			0000706698
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				870342734
		STATE OF INCORPORATION:			UT
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		7043 S 300 WEST
		CITY:			MIDVALE
		STATE:			UT
		ZIP:			84047
		BUSINESS PHONE:		8015661200
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<html>
<head>
    <title>utmdcorresp20100122.htm</title>
<!-- Licensed to: Southridge Services-->
<!-- Document Created using EDGARizerAgent 5.1.5.0 -->
<!-- Copyright 1995 - 2009 Thomson Reuters. All rights reserved. -->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center">
      <hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
      <hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><img src="logo.jpg" alt=""></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">January
22, 2010</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Eric
Atallah, Staff Accountant</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Division
of Corporation Finance</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">U.S.
Securities and Exchange Commission</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Washington,
D.C. 20549-0306</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">VIA
FACSIMILE [703-813-6985] and U.S. Certified Mail &#8211; two pages</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Re: Utah
Medical Products, Inc.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Form 10-K
for the year ended December 31, 2008</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">File No.
001-12575</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Dear Mr.
Atallah:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Thank you
for your review of Utah Medical Products, Inc.&#8217;s (UTMD&#8217;s) January 13, 2010
response to the SEC comment letter dated December 18, 2009 regarding its Form
10-K for calendar year 2008.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The first
sentence of the second paragraph of your letter dated January 21, 2010
states</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">&#8220;Please
understand that the purpose of our review process is to assist you in your
compliance with the applicable disclosure requirements and to enhance the
overall disclosure of your filing.&#8221;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As the
only comment in the January 21 follow-up letter refers to acknowledgment of
bullet points at the end of the initial comment letter, we conclude that you
were satisfied with UTMD&#8217;s responses regarding its &#8220;<font style="DISPLAY: inline; FONT-STYLE: italic">compliance with the applicable
disclosure requirements and to enhance the overall disclosure of your
filing&#8221;.</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">For ease
of reference, your sole remaining comment was</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">We
note that you did not provide all of the acknowledgments previously
requested.&#160;&#160;Please provide, in writing, a statement from the company
acknowledging that</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">&#183;&#160;&#160;the
company is responsible for the adequacy and accuracy of the disclosure in the
filing;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">&#183;
staff comments or changes to disclosure in response to staff comments do not
foreclose the Commission from taking any action with respect to the filing;
and</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#183; <font style="DISPLAY: inline; FONT-STYLE: italic">the company may not assert staff
comments as a defense in any proceeding initiated by the Commission or any
person under the federal securities laws of the United
States.</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Please
recall that UTMD did provide a statement acknowledging the first two bullet
points, and provided an explanation why it believes it would not be appropriate
for it to acknowledge the third, in its January 13 response. In all due respect,
we also requested what law or regulation might require UTMD&#8217;s acknowledgment to
the third bullet point, to which request you have not
responded.</font></div><br>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160;
</font></div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
        <div style="WIDTH: 100%; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: dimgray" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160;
</font></div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">UTMD
intends to cooperate, and believes it has a long term record of cooperation with
the SEC in fulfilling its mission.&#160;&#160;We also have a fiduciary duty to
shareholders to protect UTMD&#8217;s rights under the U.S. Constitution.&#160;&#160;If
the SEC decides to initiate some proceeding against UTMD for alleged violations
of federal securities laws related in some way to the comment letters, we will
certainly use every legal defense available, including asserting SEC staff
comments, if applicable.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As a
practical matter, instead of wasting dear taxpayer funds in litigation, we would
prefer that the SEC would provide additional comments so that UTMD can make the
necessary corrections to its public disclosures.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As you
may recall, this has been our consistent position regarding the third bullet
point in past responses to SEC comment letters.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Sincerely,</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><img src="sig.jpg" alt=""></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Kevin L.
Cornwell</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Chairman
&amp; CEO</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
      <div style="WIDTH: 100%; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2</font></div>
    </div>
    <hr style="COLOR: dimgray" noshade size="2">
  </body>
</html>


</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>sig.jpg
<TEXT>
begin 644 sig.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0!F17AI9@``24DJ``@````$`!H!!0`!
M````/@```!L!!0`!````1@```"@!`P`!`````@```#$!`@`0````3@``````
M``!@`````0```&`````!````4&%I;G0N3D54('8U+C`P`/_;`$,``P("`P("
M`P,"`P,#`P,$!P4$!`0$"08'!0<*"0L+"@D*"@P-$0X,#!`,"@H.%`\0$1(3
M$Q,+#A06%!(6$1(3$O_;`$,!`P,#!`0$"`4%"!(,"@P2$A(2$A(2$A(2$A(2
M$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$O_``!$(`#``
MJ`,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_
MQ`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C
M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-45597
M6%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ
MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X
M^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($
M!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B
M<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G
M:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X
MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@`,`P$`
M`A$#$0`_`/U3HKQBV\3:SH?[6-UX>U/4KB?0/$W@Y+_3;1Y,QV]U;3^7*$7'
M&Y)%8G/./:L/XZ>/-?\`'?C*V^#WP>O9;#6+^$3^*O$$`8_\(_8,.`&7&+B0
M<*,YP0>`V]0#?U/X^W6N^/)?"?P8\/#QC<Z5)LU[59+LVNG:8V,^49]C"6;I
M^[3IGDC#;?7[7SC;1?;/+$^P>;Y>=N['.,]LUSOPZ^''A_X5>%;3P]X(T^'3
MM.M>=J<O-(0-TDC=7<X&6//`[`"NGH`***Y_Q?X=U#Q+9+::7X@U'P\C!A+/
MIT<1G;(PH5I%8*`>>%R<#D#.0#H**\=^#_CCQ)9>.-?^&OQ4OH-6\0:):Q:E
MIFLQ6RVW]L:=(Q3S&C4[5ECD!1PN!RI'J?8J`"BN,^(WQ8T'X82>'X?$3W+W
M?B;5H=,TZUM(?-EEED8#=MSG8N06;MD=20#V=`!1110`4444`%%%%`!1110`
M4444`%%%%`'S%^TS\0;/X1?&CP1XSU2/SK?2/"7B%WB#!3*W^B")`<<%I61,
M_P"V/?/;_LP?"^]\$>"I_$'C7$_CKQS-_:WB*Y/++(XREN#CA(U.-O(#%\<$
M5YA^U)X9_P"$\_:?^!_AZ4LUI)]KN;R-""6ABFM[@AAV4FV`S]<=*^I=?\0:
M;X5T:[U;Q'?6VFZ;81&6YNKF41QQ(.I+'@4`:%%<#\'_`(W>%_CCI&I:EX"N
M+B>WTO4'LIQ<0F%]R@,'"'G8RL""0#U!`((JEXW^"9\8^.['Q5:>-O''AZZL
MH(K=K+2M12.TGB27S"'B:-LECPQSR`!0!Z7117GOQ&^.WA+X9W<6GZS=7=_K
MEP`8-%TBSDOKV4$X7]U&"5![%MH.#@F@#E=5V']L;0/(7]\/A[>_:&SG]W]N
MAV<=OFW^N?;K7ME?*WPH^(>N_%C]I77?%FE^"-9L=*T;2;?PQ<?VK<PVLVGN
M9'N9GDARS%\^0H13P.2><#ZIH`^<]*MQ\4/VS=:O;Q1/I7PFT&&SM$895=1O
M!YCRK_M"+*'TVBOHROGW]GV7'QW^/<5X!%J`URP9HS]XP&V/DOUY!7VXZ?3V
M&X^(GA6TU[^P[OQ+H$.M$@?V;)J4*W.2-P'E%MW3GITYH`Z&BBB@`HHHH`**
M\:^//Q(\1Z3KGAKP)\,)+*S\3>+?/GDU>^0/!HUA``9[DH3AW&Y0JG@G.:M_
MLO>)/$7B_P"$MIJ_C;4WUJ>\OKO[!J,EM';M=V2S,L$ICC`5=RKN^A')ZT`>
MM45SGQ%\;V/PV\"ZYXGUH_Z'HEE)<R+G!D*CY4'NS84>Y%?/G[+&O>-?%/Q4
M\5:EXTUS4-0670[2;5=.:0_9-(OKAVEBLX$QM#16Q42'.XLXW9(S0!]2UYU\
M*OBXWQ6FU:_TO2?L?A6"\DL]'U6>[&_5WB9EEDCA`^6(%3M8ME@,X%=WJUO)
M=Z7>06[*DLT#HC,<!6*D`_G7RA^Q9<S>.O#GA>UO(196_P`)+:ZTZ6!;D-Y^
MJS2.KR$(V"D=N<*2,,UQ)C_5Y(!]=4444`?)OQ4\(>)_&7[7Z2>!?$MGH7B/
MPQX+MK[15OH?M%M-'+<74-RCQ]03N0[USC:N0>,>@>&?V;;G5]6M-<_:`\4W
M?Q'U?3Y5FL+.6`6FEV+C&&2T0['<'/SOGMP*]-U/X<^'-9\:Z3XNU+2X9O$>
MAV\EO87^]E>&.3(9<`X8<MC<#C<V,9.>EH`^98O"/Q+^!OQ<\=ZM\,/!-AXW
M\,^/[N'45B76XM/ETZ["XFW^8/F5F+-\N<9'X^@^"_"'Q#\2ZW!KGQHU?3;&
MWLW6;3_#'AN21;>*4=)+FX8"2=A_<&V/.25;@CUFB@`KXZOO&&L_LS_%7XJ/
M)X%\2^+=1\>7BZCX9U;3M/:Y6X9DVBSF=1E$B<X`&3MYQTK[%HH`\N_9N^'&
MH?#3X5Z?9^*I&F\2ZK/-JNO2LX8M>W#F20$C@[<A,C@[<]Z]1HHH`\B^)G[-
MNB_$'Q6GBK2]=\4^#?$X@2WGU3PYJ/V9[J%#E4E4JRL!ZX!P`"2``/G'XM_L
M"^+IKBZO?AWXO3Q*=7F$NJV_B@()Y90&Q*LXC<%N2.44C<3N.<5]UT4`?#F@
M_!_]H[X3_#^[UK3?&%S>SZ#Y$FG>$XKG^TS<P+(#-$Q>,<A`-JQ\GY@I7@'U
M:^_;+BAT2YN['X5_%J>ZLHR]S#/X<>".#"[FWR9;`"Y/0U]&T4`?.</[<7@O
M4-#MKKP[HGC7Q#J$EOYMQI^D:#/,;9@N61I'5%.#D9&1Q6;>_MZ>&8]1TJ/3
M?!OCV]LKQ9?MDXT@H]JRJ"BJA.)"22#AA@#/.<5].A0OW0!2T`?`7QP\6>)O
MB+XXTKQSJO@_Q]X)^&D^F-X?UG4VLE>^>QED6:5A;K^\@1]HC,F3\I..3M;Z
M'\.?M;?`K2O#%G!H'C71;'2M-MDAMK00RQ-%$@"JBQ%-W``&`#7NI&>M9Q\-
M:0;PW9TO3C='K.;5-YYS][&>M`'R3^TQ\5]8^.WP=UK3?@]X(\4ZOX<BD@NK
M_P`07%D;:*2&&:.7%M!(1)<]`3\H`"GJ>G0?"7]I?X'_``Y\!V>D>$M>U35-
M3E=IKRU72;F;4M0O9"#+)*H3F1G/7=M'`!P!7U.!@8'2H8K*WAFDEA@B264Y
M=U0!F^I[T`>)Q6?CSX]R-'XIL+[X=_#Z08DTTW&S6M83CY9GC.+6$]"BL9",
M@E0:B\4?L>^$;W7(M<^'&H:]\--8CA2"2?PI="TCGC1=JJ\."AP!C@#/?->\
M44`>,?"WX&^+?`GCJ;Q!XK^*GB+QC;2Z>UH--O+<119+JRR'YV&5P^,*I^<\
)XR"5[/10!__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>logo.jpg
<TEXT>
begin 644 logo.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0!F17AI9@``24DJ``@````$`!H!!0`!
M````/@```!L!!0`!````1@```"@!`P`!`````@```#$!`@`0````3@``````
M``!@`````0```&`````!````4&%I;G0N3D54('8U+C`P`/_;`$,``P("`P("
M`P,"`P,#`P,$!P4$!`0$"08'!0<*"0L+"@D*"@P-$0X,#!`,"@H.%`\0$1(3
M$Q,+#A06%!(6$1(3$O_;`$,!`P,#!`0$"`4%"!(,"@P2$A(2$A(2$A(2$A(2
M$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$O_``!$(`'L`
M=P,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_
MQ`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C
M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-45597
M6%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ
MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X
M^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($
M!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B
M<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G
M:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X
MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@`,`P$`
M`A$#$0`_`/U3HHHH`**Y37_B7I'AO4Y+#4;/Q7-/$%+/8>$]3OHCD9&)8+=X
MSUY`8XZ'!K/_`.%T>'_^@?X[_P#""UK_`.1*`.[HKA/^%T>'_P#H'^.__"!U
MK_Y$I/\`A='A_P#Z!_CO_P`('6O_`)$H`[RBN#_X73X?_P"@?X[_`/"!UK_Y
M$H_X73X?_P"@?X[_`/"!UK_Y$H`[RBN$_P"%T>'_`/H'^.__``@M:_\`D2D_
MX71X?_Z!_CO_`,('6O\`Y$H`[RBN$_X71X?Q_P`@_P`=_P#A!:U_\B4?\+H\
M/_\`0/\`'?\`X0.M?_(E`'=T5E>'/$EIXIT\WNF0ZI#")#'MU+2KG3Y<@`Y\
MNXC1\<_>Q@\X/!K5H`****`"BBB@#Q7X:^(+>T_:!^-.EZKJ20W/VK2KZUL[
MFYVM]D_LVW1IHT8_ZOS4D4L.-RL#S7CFI^"?#OB7_A0^JZ[IT5Z_BGQSJ<=W
M<W#OF_L#::M/`K_-\T>%AD4'CY5/:M;XS_%#[7\1OB'IT_ASX?\`B'5O`$&G
M#P[HVJ:$U]J.N/<P+*;>)P^4+.Y12$903N8$`UG0?M6O>:;+K'B+1_"WB&P\
M'W7B-_$.AV&G,;OPS9V`OH;>X,S.T8,XMQ!M*J6-PVT[5<4`6(O&FN>&_B.O
MBN_AU&Q\`?%/2KG0-(:6_1K6V>VAEETB2&,'=&9X5NRQ;&7EA'856M-9^(!_
M9V^!$VM+X;BTBYU7P:)+NTU:Z>\EC:XM=NX-&%9FR-X+D'+=>_I'BWQ+XD\$
M?"C0_%_Q,TOP=J>@VUQILNJ^&[?2SMTB&6:*-'MI69A(]N9$;E%W!&V[#M%<
MW%\8O%-G^SS:_%#4],\%7OAK0;V66\\.0Z3)$UM9VE^]N'M93*RB6-(A(H,8
M!*[05X(`/1_VEXM?U3PKX?T7P!JQT;Q+K'B*W.EW&["M-:QRWJQR>L3FT"..
MZ.U?/WQC^-VJ?$;PYH/C+1Y]7\.>%[K2/$>@RZ9-N@D?5O[$O)IB_0DV\UJU
MNI'&]9B,_*:]PT/XO7OB;X":S\0]0TK1GU?PW?:X-/1HF:-/L=Y=6L;C)+*S
M11_,5(^^P&`<5!X%U3Q!\>_!]AXNT^W\&6'AR[U2XET;2-5T)K]Y+59I(6N)
M)/-41S2H96`52%$FUBV6H`\CT;P=I4<7[/%AKFC>&;2R\0ZPTNHVNGZC)<PZ
MCM\/W3H]R'5`7WC=CYAD`Y)JA\0[J[\)?%/5-'^$=S<2^%].\4>&'M+%+QWM
M;?79!?F:UA.X@(T:6;21`[59P<`L<]%J>I:QX7F^*%A%X+^&FL6/PVN=+D:S
MTKP._F7/VJW1I+H1+,Q)@CD=MB*6=$905+5[?\)KWP_XI^&-KJ6AWG@OQ1I5
MG=376F76AZ8MO;1R1DE3Y.YO*G0Y#8((.>%/%`'"_`S3_`B?`GP7\0_&%S:Z
MAKMOI4>K:QXAOK@F\_M$0EKM7?(8,K^:A@Z+MV[1M`'B?Q0\7^,/!/@GXP6?
MQ$75]%_X6EX*O?$FB"ZU)'^Q:A;1JES:0%&S&!:M9LJG!S#.WK7=_"[XQ^'_
M`!5XDT*]^*?P]\'Z;9>-M'T:>'Q);V"-'_;-_9I.]I<[P2GF;]L4A/SD&-CN
M*[NJ\(>/-6_:0UO6-%&E>$;.W\&1[+^^U;1O[3WWEPTZ+#!"[J$06RKYCEB6
M,VP``$T`?1L,\5PI:WDCE4'!*,&`/IQ4E9'A;P_:^&M$M[.QT_2=-8J)+F+2
MK06]NTY`\QE0=`6SUR<8R36O0`4444`%%%%`'CJ:5J'P^^+'C;Q'H7@_QAXD
M?QA]A>>6VGTZ.VB-O;K$!'YMPDAX'.Y1SG&17ET7P8:*PM[7_A7_`,1G5Y=:
MBU?=<:,!K6FZI<3W%QI]P!>#,:R7&8W!WH4R#\[@_6=<S\2/B1X<^$?@O5/%
MGQ"U2WT?0M(A,MS=3'\`J@<L['`51DDD`"@#Q"X\,^*M9T+1?#OC#PO\1]>\
M,:%=6EQ%83-HT4M]]E=7MTO)UO?WRJ\<;$*B;R@W9&0<71OA?XAL_!%MX)U[
MPW\2-9\%V^H/>R:25T2V:[#7;77DSS+>EFB\QN0H4L!M)P2#^:?[8O\`P4L\
M=?M#ZK=:+\/;O4/!7@"*3;#9VDYBN]1`.1)<RH<X.`1&IVCON(S7RM_PLOQ?
M_P!#5XD_\&L__P`50!^\UIX*\2V%CK&@VGA3XB)X(UO5KC4KCP__`,24LC7$
MYN+B".Y%Z&6"25W8J5+`.RA@,8TO!>F>,OATCZ9X,\+>/['PK_:,E[!HTL>B
MS-9B65I9;>&<WH*PEW?`9&9`V%8`+C\OO^"5_C3Q#K?[9GA:UUG7M:O[5M.U
M(M!<ZA+*C$6LF,JS$'%?N5+_`*I_]TT`?/PL/%=AXA\<:_X8\(?$+2-8\;W&
MGSR3;M$N$LS:1)$%5&O/G61$(;)!&X[2#@UH>`_[<\"Z7KL$?PV\;WM[XGU2
M?5-6O/M&CP":YF1$9DC6\P@"QH`,DG;DDDDG^??Q%XX\1IX@U-4\0:X%6\E`
M']HR_P!\_P"U5&+Q_P"*()4E@\2:_')&P9'34I@5(Y!!W<&@#][_``?\.QX9
M^'U]X,U?X6^._$NAZEHFGZ/=PZC=:.OFQ6=JENC_`"7@PY"!\C!5L%2,`UF?
M#[X9^(_A(8)/AOX=^)MG<OIL5AJLFJOHVH#55A>5H9Y<WJ,+A!,R&0-AU"[E
M)`(^0OV(/^"KU_I=[I_@C]J2^:_TZ9U@L/&$@_?6Q)PJWF/OQ_\`37[PZMN&
M6'ZSVUS%>6\5Q:2QSP3H'BEC8,KJ1D,"."".<B@#E/AC)KTN@7#^,_[<%Z]_
M,T2:Q#91S1PD@HG^B.T950=H8G<<$D=*Z^BB@`HHHH`****`&331V\+RW#I%
M%$I9W=@JJH&223T&*_!3_@HE^V?>?M/_`!.FT?PK=R)\./"MR\6CPHQ"ZA*,
MJ]ZX[[N0@/W4]"S5^D/_``53_:`?X.?LU7VA:!>>1XA\?3#28O+?$D-HRL;F
M08.0"BF+/_37VK\)*`"BO3/@C\"-:^-LGB^;1F%MI?@?PQ?^(-7O77*Q16\+
MND8]7D=50#TW-T4UYG0!]A?\$G/^3U_"O_8-U/\`]))*_>.;_5/_`+IK\'/^
M"3G_`">OX5_[!NI_^DDE?O'-_JG_`-TT`?RU^)/^1BU3_K]F_P#0S6=6CXD_
MY&+5/^OV;_T,UJ?#+P6WQ'^(_A?PG'=+8OXFUBUTU;IDWB`SRK&'([@%LX]J
M`.:K]4O^"2?[:-S-=P_`_P")=^TT;1L_@Z]N),E-H+/8DGMM!:/TPR]T`_,[
MXA^`M9^%WCG7/"7C&U-GK7AZ^DL[R'.0'0XRI[J1A@>X(/>J'AGQ'J/@_P`1
MZ7KOARZDLM5T:\BO+*YC.&BFC<.C#Z,`:`/ZEJ*YWX=>.-/^)G@'P[XM\/OO
MTWQ)IEOJ%MSDA)8PX4^XS@^X-=%0`4444`%%%%`'XA_\%C?&TOB']JNVT,2L
M;;PMX;M+?RL\++*TD[-]2LL8_`5\)U]6_P#!4I)%_;I^)!D#!6723'GH5_LN
MT''MD']:^4J`/UO_`&+?A/;^"/\`@E_\6O%4D`75/'WAW7KJ28CYC;06TT$*
M?0,DSC_KH:_)"OW7^#MJ-0_X)0+;:0GFO/\`"[545%_BD,%P&'_?6:_"B@#[
M"_X).?\`)Z_A7_L&ZG_Z225^\<W^J?\`W37\_G_!-#QWHOP]_;'\$W_BZ]AT
MZPO1=Z>MU.X6..:>W>.(,QX`9RJY]6%?O1X[\9Z/\//!VL^)?&%]!INC:+9R
M7-Y<S.%5$52>_4GH!U)(`Y-`'\PWB3_D8M4_Z_9O_0S7>?LP?\G)?"K_`+'3
M2?\`TKBKSO5;L7^IWETBE5N9WD"GL&8G'ZUZ7^RE8S:E^TY\*+>T4O*_C/2B
M`/0749)_``F@#[,_X+3_``@MO#OQ2\'_`!"TNW6(>+]/DL=29!C?<VNW8[>Y
MBD5?I$*_-^OV%_X+=/"/@]\.D;;]H;Q+,8_78+9MWX9*_I7X]4`?O1_P2C\9
MR>+OV,?#-O<RF67PUJ%]I3,>H59C*B_@DR#Z`5]@5\!?\$5U=?V5O$QD#!6\
M?7A3/<?8;`<?B#7W[0`4444`%%%%`'XH?\%EO`%QH'[3&E^)HX&^P>*/#EL6
MG"G:;B%Y(F4GU\M8C]#7P-7[\?\`!2_]GV7X\_LR:PV@VIN?$G@V0:WIB(N7
MF6)6$\(QR2T3.0.[*HK\!Z`/VN_X)$?%33OB3^S#J/P]U=XY[[P7>SVTUI(0
M3)879:1&Q_=WM.GMM'J*_*C]J/X#ZI^S?\;_`!+X)UF*46]E<M-I-RXXO+&0
MDP2@]\K\I]&5AVJY^RA^TIK?[*_QATWQEX?5[NQQ]EUK3-^U=0LG(+QY[,"`
MRMV91U&0?V2^+_P9^$O_``4P^!NDZ_X8U:(7<<;-H?B&VC!N=,F(!DMKB/.2
MN<;XB1SAE/0D`_`JNBUGXD>+?$>B6VC>(?%'B+5-(L\?9["\U2::"''3;&S%
M5Q["O:_CC_P3^^-GP)U*X76?!^H>(='B8^5K7AZ%[ZVD3)PS!!OC^CJOXUXA
M9^`/%&H7@L[#PWKUS=EMH@ATV5Y,^FT+G-`&#7W;_P`$B_V?KWXC_M!+X_U&
MU?\`X1SX=QM,)V4[)M0E0I#&/4JK/*?3:F?O"L']F_\`X)9?%KXS:I:7?Q!T
MZY^'7A0LK7%WJT.V\F3@E8;8X?<1WDVJ.O/0_HO\;_C/\,?^":/[/=CX6^']
MI:G7&MG3P[H7F!Y[VX(P][=L,'9NY9SC<0$7'\(!\3_\%FOC-;>,?C5X<\`Z
M/<+-!X$T]Y=0V,"%O;K8Q0^ZQ)$?;S"*_/&M7Q7XIU7QOXFU7Q!XJO9M1UC6
MKN2\OKJ8Y:::1BS,?J2>.U7/AWX#U?XH>.M!\)>$K=KK6/$5_%96D8'&]V`W
M-Z*HRQ/8`GM0!^Z?_!+7P-)X)_8Q\'O=Q^5<>(Y[O5Y%QU669EB/XQ1QG\:^
MM*R?"?AG3_!7A?1_#_A^$6^F:'8PV-G$/X(8D"(/^^5%:U`!1110`4444`(1
MD<U^'7_!3+]B2Z^`/C^Y\>>`-/=OAUXJNS(RP)E=&O7)+0,!]V)CEHST'*?P
MC=^XU9/BOPIH_CKPWJ/A_P`8:;::OHNK6[6][8W<8>.>-NH(/Y@]00",$4`?
MRVU^D/\`P1B^&OC/5?B5XB\9V.LZKI7@71;?[)?6<4F+?6;V1?W<;J>#Y2DR
M%A\P+1C.&-9/[5__``24\9^!/$HU7]G2WN/%WA34KM4736D!OM)+L``V?];"
M"?OCYE`RPP"Q_4_]FSX&Z5^SE\&/#?@3P^(Y/[)M@U_=*N#>7C_-/,>_S.3C
M/10H[4`>G4F*6B@!&7<I`)7(QD=17\ZG[<_PV\9?"W]I?Q;I7Q0UC5?$=[<7
M'VS3]:U&0R2:A8R$F%\]!@`H57"JR,```*_HLKXO_P""GG[)-S^T9\(;?7_`
M>FO?>//!3&6QMX$S+J%HY'G6P'\3#B11ZJP'+T`?A/7["?\`!*']B>Y^'FF+
M\8_BCI[VWB#6K4Q^&;"X3#V-G(/FN74_=DE7A1U$9/\`?P,S]AG_`()3_P#"
M&ZGIWCS]IRWM+O5;5EGTSPF'6>&VD'*R7;#*R,#R(U)4'EBWW1^FW3I0`M%%
H%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`'_V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
